Press release: RSSL and ERBC announce strategic partnership

RSSL and ERBC announce strategic partnership to deliver seamless, end-to-end drug development support

RSSL, a leading Life Sciences Contract Research Organisation (CRO) and ERBC, a specialist in preclinical research and regulatory studies, have announced a strategic partnership designed to deliver integrated, end-to-end drug development support for pharmaceutical and biotech clients worldwide.

Bringing together decades of complementary scientific expertise, this collaboration unites ERBC’s excellence in preclinical safety, toxicology, and regulatory science with RSSL’s industry-leading GMP analytical capabilities and regulatory consultancy. The result is a cohesive, streamlined offering that spans the full drug development lifecycle – from early discovery through to commercialisation.

“We’re excited to partner with ERBC as we continue to expand our scientific reach and support clients in accelerating the development of life-changing therapies. This collaboration strengthens our ability to deliver high-quality, fully integrated services that meet the complex needs of today’s pharmaceutical landscape.”
Jacinta George, MD & VP, RSSL

With more than 750 scientists across 10 European sites and deep sector experience, the partnership creates a robust scientific network that simplifies outsourcing, reduces development timelines and strengthens regulatory outcomes. Clients benefit from fewer handoffs, clearer project ownership and greater strategic continuity across all phases of development.

“Partnering with RSSL represents a natural evolution for ERBC. By combining our strengths, we’re creating a unique proposition for clients that supports their journey from preclinical proof-of-concept to product launch with unmatched efficiency and scientific rigour. We look forward to the opportunities this partnership will unlock for both our teams and our clients.”
Christophe Priou, CEO at ERBC.

Together, RSSL and ERBC are redefining what end-to-end drug development support looks like with smarter strategies, stronger science and seamless execution. In 2025 and beyond, the partnership will hit the road, co-exhibiting at major industry events to showcase the full power of their combined expertise and demonstrate what’s possible when two leaders join forces.

For media enquiries or further information, please contact: